or
forgot password
  • cancer clinical trials in ogden, UT

  • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Prostate Cancer
    Vaccine Therapy for Patients With Stage IV Melanoma
    Intermountain Health Care- Mckay-Dee Hospital
    Ogden, Utah 84403
    Malignant Melanoma
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Breast Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Breast Cancer
    Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Prostate Cancer
    Vaccine Therapy for Patients With Stage III Melanoma
    Intermountain Health Care- Mckay-Dee Hospital
    Ogden, Utah 84403
    Malignant Melanoma
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Esophageal Cancer, Gastric Cancer
    S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Lung Cancer
    Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Endometrial Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Breast Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Breast Cancer
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Metastatic Cancer, Prostate Cancer
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Leukemia
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Breast Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Head and Neck Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Cervical Cancer, Endometrial Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Prostate Cancer
    Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
    Research Center In
    Ogden, Utah
    Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer
    Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Breast Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Breast Cancer
    Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Anal Cancer
    Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Lung Cancer
    S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Leukemia
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Colorectal Cancer
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Colorectal Cancer
    Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer
    ImClone Investigational Site
    Ogden, Utah 84403
    Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Lung Cancer
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Endometrial Cancer, Fatigue, Neurotoxicity
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
    Ogden, Utah 84403
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    McKay-Dee Hospital Center
    Ogden, Utah 84403
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma